Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-10004 in Discoid Lupus Erythematosus
NCT00708916Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in discoid lupus erythematosus (DLE), sponsored by NYU Langone Health. Started Jun 2008; status: completed.
02
Drugs
apremilast
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on NCT00708916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708916.